Sarepta Therapeutics Inc (SRPT)

Debt-to-assets ratio

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Long-term debt	US$ in thousands	1,132,520	1,544,290	1,096,880	992,493	681,900
Total assets	US$ in thousands	3,264,580	3,128,370	3,147,970	2,984,720	1,822,820
Debt-to-assets ratio		0.35	0.49	0.35	0.33	0.37

December 31, 2023 calculation

Debt-to-assets ratio = Long-term debt ÷ Total assets
= $1,132,520K ÷ $3,264,580K
= 0.35

The debt-to-assets ratio for Sarepta Therapeutics Inc has fluctuated over the past five years, indicating changes in the company's debt management and asset utilization. In 2022, the ratio reached its highest point of 0.49, suggesting a higher proportion of the company's assets were financed by debt that year. This could indicate increased leverage and financial risk.

However, in 2023, the debt-to-assets ratio decreased to 0.35, which could signify improved debt management or a higher level of asset backing for the company's liabilities. Despite the fluctuation, the ratio has remained relatively stable between 0.33 and 0.37 over the five-year period, indicating a moderate level of debt relative to the company's asset base.

Overall, the trend in Sarepta Therapeutics Inc's debt-to-assets ratio suggests that the company has been managing its debt levels prudently and maintaining a balance between debt and asset levels in its capital structure.